Arthritis and antithyroid agents
Escobar Oliva, B.; Pérez Villarroya, J.C.
Atencion Primaria 27(3): 209-210
2001
ISSN/ISBN: 0212-6567 PMID: 11265526 Document Number: 533309
Document emailed within 1 workday
Related Documents
Stoll, R.; Faucounau, N.; Maraud, R. 1970: Co-teratogenic action of antithyroid agents in the chick embryo Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 164(3): 546-548Van Zyl, A.; Lubbe, S.; Potgieter, A.; Van Zyl, J. 1979: The influence of non-steroidal anti-inflammatory and antithyroid agents on myeloperoxidase-catalysed activities of human leucocytes South African Medical Journal 55(26): 1082-1087
Iitaka, M.; Aguayo, J.; Row, V.V.; Ruf, J.; Carayon, P.; Volpé, R. 1988: Comparison of measurements of in vitro production of antithyroid microsomal antibody versus antithyroid peroxidase antibody Regional Immunology 1(2): 106-110
Urbannek, V.; Voth, E.; Moka, D.; Schicha, H. 2001: Radioiodine therapy of Graves' disease--a dosimetric comparison of various therapy regimens of antithyroid agents NUKLEARMEDIZIN. Nuclear Medicine 40(4): 111-115
Horsmans, Y.; Larrey, D.; Pessayre, D.; Benhamou, J.P. 1990: Hepatotoxicity of antimicrobial agents. II: Urinary antiseptics, antitubercular agents, antiparasitic agents, antifungal agents, antiviral agents Gastroenterologie Clinique et Biologique 14(12): 919-924
Merkel, P.A.; Letourneau, E.N.; Polisson, R.P. 1995: Investigational agents for rheumatoid arthritis Rheumatic Diseases Clinics of North America 21(3): 779-796
Ridolfo, A.S. 1978: Nonsteroidal anti-inflammatory agents in arthritis American Family Physician 17(2): 131-138
Koh, E.T. 2001: New disease modifying agents in adult rheumatoid arthritis Annals of the Academy of Medicine Singapore 30(2): 170-173
Gaines, L.M. 1982: Rheumatoid arthritis V: therapy with remission-inducing agents Maryland State Medical Journal 31(9): 49-50
Huppertz, H.I. 1997: Initiation of chronic arthritis by infectious agents: experimental evidence Revue du Rhumatisme 64(10 Suppl): 156s-157s
Carreira Delgado, P.E.; Gómez-Reino Carnota, J.J.; Morillas López, L.; Ibero Díaz, I.; Mateo Bernardo, I. 1986: Effectiveness and safety of immunosuppressive agents in the treatment of rheumatoid arthritis Medicina Clinica 86(14): 575-578
Wilder, R.L. 1987: Proinflammatory microbial products as etiologic agents of inflammatory arthritis Rheumatic Diseases Clinics of North America 13(2): 293-306
Ranganathan, P. 2008: An update on pharmacogenomics in rheumatoid arthritis with a focus on TNF-blocking agents Current Opinion in Molecular Therapeutics 10(6): 562-567
Strand, V.; Scott, D.L.; Panayi, G.S. 1994: Evaluating biologic agents in rheumatoid arthritis: a framework for clinical trials Journal of Rheumatology 21(8): 1390-1392
Henderson Berg, M.-H.; Carrasco, D. 2017: Injection Site Reactions to Biologic Agents Used in Psoriasis and Psoriatic Arthritis Journal of Drugs in Dermatology: Jdd 16(7): 695-698
Roth, S.H. 1986: Treating arthritis with non-steroidal anti-inflammatory agents (NSAIDS) without damaging the stomach Spine 11(1): 103
Rodríguez Moreno, J.; Valverde García, J.; Castelao, A.M.; Roig Escofet, D.; Juanola Roura, X.; Gil Suárez, M.L.; Belmonte Serrano, M. 1987: Renal insufficiency in rheumatoid arthritis. Effect of non-steroidal anti-inflammatory agents Medicina Clinica 89(8): 324-327
Valesini, G.; Montecucco, C.; Cutolo, M. 2006: Recommendations for the use of biologic (TNF-alpha blocking) agents in the treatment of rheumatoid arthritis in Italy Clinical and Experimental Rheumatology 24(4): 413-423
Criswell, L.A.; Henke, C.J. 1995: What explains the variation among rheumatologists in their use of prednisone and second line agents for the treatment of rheumatoid arthritis? Journal of Rheumatology 22(5): 829-835
Paulus, H.E.; Johnston, K.R.; Lachenbruch, P.A. 1992: Practice based evaluation of the longterm benefit of second line agents in rheumatoid arthritis Journal of Rheumatology. Suppl 32: 80-84